Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Imec and Veeco Announce Collaboration

Published: Friday, September 27, 2013
Last Updated: Friday, September 27, 2013
Bookmark and Share
Both Companies collaborate in GaN-on-Si devices for LED and power electronics applications.

Nanoelectronics research centre imec of Belgium and Veeco Instruments Inc. are collaborating on a project aimed at lowering the cost of producing gallium nitride on silicon (GaN-on-Si) -based power devices and LEDs.

Barun Dutta, imec’s Chief Scientist, commented, “The productivity, repeatability, uniformity and crystal quality of Veeco’s metal organic chemical vapor deposition (MOCVD) equipment has been instrumental in helping us meet our development milestones on GaN-on-Si for power and LED applications. The device performance enabled by the epi has helped us realize state-of-the-art D-mode (depletion mode) and E-mode (enhancement mode) power devices. Our goal is to establish an entire manufacturing infrastructure that allows GaN-on-Si to be a competitive technology.”

Imec’s multi-partner GaN-on-Si research and development program gathers the industry to jointly develop world-class GaN LED and power devices on 200 mm silicon substrates compatible with a 200 mm CMOS-compatible infrastructure.

By joining forces at imec, companies share costs, talent and intellectual property to develop advanced technologies and bring them to the market faster.

Jim Jenson, Senior Vice President, General Manager, Veeco MOCVD, commented, “We have been working with imec on this program since 2011 and are encouraged by our progress. Our work is mutually rewarding, as we are both focused on being able to realize lower costs while maintaining world-class performance on GaN-on-Si devices. This technology can be used to create lower cost LEDs that enable solid state lighting, more efficient power devices for applications such as power supplies and adapters, PV inverters for solar panels, and power conversion for electric vehicles.”

Veeco’s MOCVD equipment features excellent film quality and low defects, which are key for effective GaN-on-Si processing. It also incorporates Veeco's Uniform FlowFlange® technology for superior uniformity and excellent run-to-run repeatability.

Low maintenance TurboDisc® technology enables highest system availability, excellent particle performance and high throughput.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Veeco Ships 50th EPIK 700 MOCVD Reactor in Less Than a Year
Delivered increased LED wafer production with best-in-class uniformity and easy process transfer.
Wednesday, August 12, 2015
Veeco Wins Innovation Award with EPIK700 MOCVD System
CS Industry Innovation Award for the highest distinction in compound semiconductor manufacturing.
Friday, April 03, 2015
Veeco Appoints Shubham Maheshwari as Chief Financial Officer
Mr. Maheshwari replaces David D. Glass.
Friday, May 16, 2014
Veeco Completes Purchase of Synos Technology
Veeco granted equity awards to 52 Synos employees.
Friday, October 04, 2013
Veeco to Purchase Synos Technology
Fast array scanning ALD technology enables flexible OLED displays.
Friday, September 20, 2013
NANEO Precision IBS Coatings GmbH Expands Manufacturing Capacity
NANEO has recently ordered a SPECTOR® Ion Beam Deposition system.
Monday, July 01, 2013
Hangzhou Silan Azure Expands Manufacturing Capacity with Veeco MOCVD
Veeco's TurboDisc® K465i™ MOCVD systems will be used to expand Silan’s manufacturing capacity for HB LEDs.
Tuesday, October 30, 2012
HC SemiTek Purchases Additional Veeco MOCVD Systems
HC SemiTek has purchased TurboDisc® MaxBright® GaN MOCVD systems for LED production.
Tuesday, October 23, 2012
SemiLEDs Qualifies Veeco MOCVD System
Veeco TurboDisc® K465i™ GaN MOCVD system for high volume LED production.
Thursday, February 09, 2012
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos